These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 7702404

  • 1. Treatment of carrageenan induced arthritis by the platelet activating factor antagonist BN 50730.
    Hilliquin P, Natour J, Aissa J, Guinot P, Laoussadi S, Benveniste J, Menkes CJ, Arnoux B.
    Ann Rheum Dis; 1995 Feb; 54(2):140-3. PubMed ID: 7702404
    [Abstract] [Full Text] [Related]

  • 2. Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis.
    Miguélez R, Palacios I, Navarro F, Gutierrez S, Sanchez-Pernaute O, Egido J, González E, Herrero-Beaumont G.
    J Lipid Mediat Cell Signal; 1996 Jan; 13(1):35-49. PubMed ID: 8821809
    [Abstract] [Full Text] [Related]

  • 3. Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits.
    Yue TL, Farhat M, Rabinovici R, Perera PY, Vogel SN, Feuerstein G.
    J Pharmacol Exp Ther; 1990 Sep; 254(3):976-81. PubMed ID: 2395125
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New trends in PAF antagonist research: a new series of potent hetrapazine-derived PAF antagonists.
    Braquet P, Esanu A.
    Agents Actions; 1991 Jan; 32(1-2):34-6. PubMed ID: 2058466
    [No Abstract] [Full Text] [Related]

  • 7. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats.
    Teather LA, Magnusson JE, Wurtman RJ.
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):430-3. PubMed ID: 12373444
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo.
    Yue TL, Rabinovici R, Farhat M, Feuerstein G.
    J Lipid Mediat; 1991 Oct; 3(1):13-26. PubMed ID: 1768837
    [Abstract] [Full Text] [Related]

  • 9. Prevention of chloroquine-induced electroretinographic damage by a new platelet-activating factor antagonist, BN 50730.
    Doly M, Cluzel J, Millerin M, Bonhomme B, Braquet P.
    Ophthalmic Res; 1993 Oct; 25(5):314-8. PubMed ID: 8259265
    [Abstract] [Full Text] [Related]

  • 10. Platelet-activating factor induces collagenase expression in corneal epithelial cells.
    Bazan HE, Tao Y, Bazan NG.
    Proc Natl Acad Sci U S A; 1993 Sep 15; 90(18):8678-82. PubMed ID: 8378347
    [Abstract] [Full Text] [Related]

  • 11. Effect of BN 50727 on pathological findings and tissue platelet activating factor levels during ileal ischemia in newborn piglets.
    de Boissieu D, Canarelli JP, Cordonnier C, Richard S, Léké A, Tarrade T, Postel JP, Dupont C.
    J Pediatr Surg; 1996 Dec 15; 31(12):1675-9. PubMed ID: 8986985
    [Abstract] [Full Text] [Related]

  • 12. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M, Tomomatsu N, Iwahisa Y, Yamaguchi S, Kawakami Y, Terasawa M.
    Pharmacology; 1997 May 15; 54(5):261-70. PubMed ID: 9380772
    [Abstract] [Full Text] [Related]

  • 13. A platelet activating factor receptor antagonist prevents the development of chronic arthritis in mice.
    Palacios I, Miguélez R, Sánchez-Pernaute O, Gutierrez S, Egido J, Herrero-Beaumont G.
    J Rheumatol; 1999 May 15; 26(5):1080-6. PubMed ID: 10332972
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of rheumatoid arthritis with platelet activating factor antagonist BN 50730.
    Hilliquin P, Guinot P, Chermat-Izard V, Puechal X, Menkes CJ.
    J Rheumatol; 1995 Sep 15; 22(9):1651-4. PubMed ID: 8523338
    [Abstract] [Full Text] [Related]

  • 16. Platelet-activating factor antagonist BN 50730 attenuates hypoxic-ischemic brain injury in neonatal rats.
    Liu XH, Eun BL, Barks JD.
    Pediatr Res; 2001 Jun 15; 49(6):804-11. PubMed ID: 11385142
    [Abstract] [Full Text] [Related]

  • 17. Protection against ventricular fibrillation by the PAF antagonist, BN-50739, involves an ischaemia-selective mechanism.
    Baker KE, Curtis MJ.
    J Cardiovasc Pharmacol; 1999 Sep 15; 34(3):394-401. PubMed ID: 10470998
    [Abstract] [Full Text] [Related]

  • 18. Platelet-activating factor (PAF-acether) and microcirculation: effect of Lyso-PAF and PAF-antagonists.
    Lagente V, Fortes ZB, Garcia-Leme J, Vargaftig BB.
    Braz J Med Biol Res; 1987 Sep 15; 20(5):595-7. PubMed ID: 3452452
    [Abstract] [Full Text] [Related]

  • 19. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
    Rabinovici R, Yue TL, Farhat M, Smith EF, Esser KM, Slivjak M, Feuerstein G.
    J Pharmacol Exp Ther; 1990 Oct 15; 255(1):256-63. PubMed ID: 2213560
    [Abstract] [Full Text] [Related]

  • 20. [PAF receptor antagonist in asthma therapy].
    Sagara H, Makino S, Fukuda T.
    Nihon Rinsho; 1996 Nov 15; 54(11):3056-61. PubMed ID: 8950954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.